日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Somatic mutations in FAS pathway increase hemophagocytic lymphohistiocytosis risk in patients with T- and/or NK-cell lymphoma

FAS 通路体细胞突变增加 T 细胞和/或 NK 细胞淋巴瘤患者罹患噬血细胞性淋巴组织细胞增生症的风险

Ying Liu, Rohan Sardana, David Nemirovsky, Denise Frosina, Achim Jungbluth, William T Johnson, Santosha Vardhana, Maria Arcila, Steven M Horwitz, Andriy Derkach, Ahmet Dogan, Wenbin Xiao

Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant

第三方巨细胞病毒特异性T细胞可提高造血干细胞移植后难治性巨细胞病毒血症患者的生存率

Susan E Prockop ,Aisha Hasan ,Ekaterina Doubrovina ,Parastoo B Dahi ,Irene Rodriguez-Sanchez ,Michael Curry ,Audrey Mauguen ,Genovefa A Papanicolaou ,Yiqi Su ,JinJuan Yao ,Maria Arcila ,Farid Boulad ,Hugo Castro-Malaspina ,Christina Cho ,Kevin J Curran ,Sergio Giralt ,Nancy A Kernan ,Guenther Koehne ,Ann Jakubowski ,Esperanza Papadopoulos ,Miguel-Angel Perales ,Ioannis Politikos ,Keith Price ,Annamalai Selvakumar ,Craig S Sauter ,Roni Tamari ,Teresa Vizconde ,James W Young ,Richard J O'Reilly

MET-dependent solid tumours - molecular diagnosis and targeted therapy

MET 依赖性实体肿瘤 - 分子诊断和靶向治疗

Robin Guo, Jia Luo, Jason Chang, Natasha Rekhtman, Maria Arcila, Alexander Drilon

JAK2 inhibition sensitizes resistant EGFR-mutant lung adenocarcinoma to tyrosine kinase inhibitors

JAK2 抑制使耐药 EGFR 突变肺腺癌对酪氨酸激酶抑制剂敏感

Sizhi P Gao, Qing Chang, Ninghui Mao, Laura A Daly, Robert Vogel, Tyler Chan, Shu Hui Liu, Eirini Bournazou, Erez Schori, Haiying Zhang, Monica Red Brewer, William Pao, Luc Morris, Marc Ladanyi, Maria Arcila, Katia Manova-Todorova, Elisa de Stanchina, Larry Norton, Ross L Levine, Gregoire Altan-Bonn

Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer

AXL 激酶的激活导致肺癌对 EGFR 靶向治疗产生耐药性

Zhenfeng Zhang, Jae Cheol Lee, Luping Lin, Victor Olivas, Valerie Au, Thomas LaFramboise, Mohamed Abdel-Rahman, Xiaoqi Wang, Alan D Levine, Jin Kyung Rho, Yun Jung Choi, Chang-Min Choi, Sang-We Kim, Se Jin Jang, Young Soo Park, Woo Sung Kim, Dae Ho Lee, Jung-Shin Lee, Vincent A Miller, Maria Arcila,

Identification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusions

通过基于 mRNA 的全面酪氨酸激酶融合筛查鉴定肺腺癌中的 KIF5B-RET 和 GOPC-ROS1 融合

Yoshiyuki Suehara, Maria Arcila, Lu Wang, Adnan Hasanovic, Daphne Ang, Tatsuo Ito, Yuki Kimura, Alexander Drilon, Udayan Guha, Valerie Rusch, Mark G Kris, Maureen F Zakowski, Naiyer Rizvi, Raya Khanin, Marc Ladanyi

Assessment of EGFR mutation status in lung adenocarcinoma by immunohistochemistry using antibodies specific to the two major forms of mutant EGFR

使用针对两种主要突变型 EGFR 的特异性抗体通过免疫组织化学法评估肺腺癌中的 EGFR 突变状态

Marie Brevet, Maria Arcila, Marc Ladanyi